Allergic diseases of the skin and drug allergies – 2031. Effectiveness of autologous serum therapy in patients of chronic urticaria: a randomized, single-blind, controlled trial by unknown
MEETING ABSTRACT Open Access
Allergic diseases of the skin and drug allergies –
2031. Effectiveness of autologous serum therapy
in patients of chronic urticaria: a randomized,
single-blind, controlled trial
Panchami Debbarman
From 2nd WAO International Scientific Conference (WISC 2012)
Hyderabad, India. 6-9 December 2012
Background
Chronic urticaria (CU) is a vexing problem to clinicians
and patients alike. Search for newer modalities which
can reduce pill burden is a felt need. The scope of Auto-
logous serum therapy (AST) thus needs evaluation.
Methods
Patient blind, parallel group, randomised, controlled study
of two study arm. 54 patients were given AST (GroupA)
and control group of 57 patients given injection normal
saline (placebo) (GroupB). AST/Placebo was given every
week for 9 weeks and then followed-up for another
3 weeks. Levocetrizine was advised to be taken SOS in
both groups. AU was diagnosed by autologous serum skin
test. Urticaria total severity score (TSS) and Bengali
version of Dermatologic life quality index (DLQI) was
used as primary efficacy variable. Mann-Whitney U test
and Freidman’s ANOVA followed by post hoc Dunn’s test
was used for analysis.
Results
TSS was comparable (p>0.05) at baseline in Group A
(17.74±0.44) and Group B (17.31±0.66). TSS showed sig-
nificant improvement (p<0.001) from baseline 7th week
(12.56±2.24) onwards in group A and 8th week (13.29
±1.80) onwards in group B which continued till end-of-
treatment visit. Between group comparison showed signifi-
cant improvement (p<0.001) 4th week onwards which
persisted till 12th week. DLQI showed significant improve-
ment (p=0.006) in Group A than Group B at the end of
study. Both AU and non-AU patients showed comparable
(p>0.05) improvement of TSS.
Conclusions
AST shows promise in treatment of urticaria regardless
of the autoimmune nature.
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